Detalhe da pesquisa
1.
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
Lancet
; 401(10382): 1091-1102, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924778
2.
Cardiometabolic profiles in children and adults with overweight and obesity and down syndrome.
Am J Med Genet A
; 191(3): 813-822, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538912
3.
A Systematic Review of Fragile X-Associated Neuropsychiatric Disorders.
J Neuropsychiatry Clin Neurosci
; 35(2): 110-120, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172690
4.
Unexplained regression in Down syndrome: Management of 51 patients in an international patient database.
Am J Med Genet A
; 188(10): 3049-3062, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924793
5.
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.
Future Oncol
; 17(21): 2747-2758, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849298
6.
Response to Letter to the Editor by Palffy and Ghaziuddin.
Am J Med Genet A
; 191(5): 1470-1473, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609854
7.
Psychopathology of adolescents with an intellectual disability who present to general hospital services.
Australas Psychiatry
; 25(5): 481-485, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28462590
8.
Prescribing psychotropic drugs to adults with an intellectual disability.
Aust Prescr
; 39(4): 126-130, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756975
9.
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Invest New Drugs
; 32(5): 937-45, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916770
10.
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.
Ann Clin Transl Neurol
; 11(4): 1034-1045, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375538
11.
Adult with autism spectrum disorder presenting with insidious onset of catatonia.
Aust N Z J Psychiatry
; 52(11): 1092-1093, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30264575
12.
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial.
Obstet Gynecol
; 141(4): 737-747, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897180
13.
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.
J Clin Endocrinol Metab
; 108(8): 1981-1997, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734148
14.
Interprofessional Teamwork and Collaboration Between Community Health Workers and Healthcare Teams: An Integrative Review.
Health Serv Res Manag Epidemiol
; 2: 2333392815573312, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-28462254